Vestal Point Capital’s Globus Medical GMED Stock Holding History

Vestal Point Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.2M	Buy	850,000 +239,480	+39%	+$20.4M	1.57%	22
2026 Q1	$52.6M	Sell	610,520 -664,480	-52%	-$59.6M	1.47%	24
2025 Q4	$111M	Buy	1,275,000 +25,000	+2%	+$1.9M	3.78%	6
2025 Q3	$71.6M	Buy	1,250,000 +750,000	+150%	+$43.2M	3.23%	8
2025 Q2	$29.5M	Buy	500,000 +300,000	+150%	+$19.4M	1.55%	22
2025 Q1	$14.6M	Sell	200,000 -125,000	-38%	-$10.3M	1.05%	33
2024 Q4	$26.9M	Buy	+325,000	New	+$25.6M	1.59%	26
2024 Q3	–	Sell	-900,000	Closed	-$61.6M	–	78
2024 Q2	$61.6M	Sell	900,000 -100,000	-10%	-$5.97M	4.6%	5
2024 Q1	$53.6M	Buy	1,000,000 +200,000	+25%	+$10.8M	4.44%	5
2023 Q4	$42.6M	Buy	+800,000	New	+$39M	4.52%	7

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vestal Point Capital's GMED Position: Q2 2026 in Review

Vestal Point Capital increased its Globus Medical (GMED) stake by 39% in Q2 2026, buying an estimated $20.4M and bringing the position to 850,000 shares worth $67.2M. The position accounts for 1.57% of the portfolio, ranked #22.

Vestal Point Capital first reported a position in GMED in Q4 2023 and has held it in 10 quarters since. The position peaked at $111M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Vestal Point Capital held 850,000 shares of Globus Medical worth $67.2M as of Q2 2026.
Vestal Point Capital bought 239,480 Globus Medical shares in Q2 2026, an estimated $20.4M.
Globus Medical made up 1.57% of Vestal Point Capital's portfolio in Q2 2026, its #22 holding.
Vestal Point Capital first reported a position in Globus Medical in Q4 2023 and has held it in 10 quarters since.
Vestal Point Capital's Globus Medical position peaked at $111M in Q4 2025.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.